Ethical Consideration

 | Post date: 2018/01/27 | 

Ethics of SBRH Publishing
 Details of formal ethical approval should be stated in the main body of the article. If authors were not required to obtain ethical approval (as is the case in some countries) or unable to obtain it (as sometimes occurs in resource-poor settings), they should explain the reason. Please anonymize this information in the manuscript, and only if requested give the information during submission. The procedures for securing informed consent should be provided.
 Complying with medical ethics, anonymity, and confidentiality are among the points to be considered. In this regard, protecting the human subjects according to
 Helsinki Declaration should be taken in to consideration and the ethics committee confirmation letter of the university must be attached to the article. Medical research studies involving human subjects must generally be accepted in terms of scientific principles and a letter of consent from parents or legal caretakers is necessary.
 According to
 ICMJE website "A Clinical Trial is any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". Authors who conducted studies in this scope should register their trial in one of the ICMJE-recognized trial registries. Therefore, the number of clinical trial registration should be attached to submitted paper.

Ethics of studies involving humans and animals
 The research that involves human beings and animals must adhere to the principles of the Declaration of Helsinki (
 All research participants should be informed about the aims of the study and any possible side effects of the drugs and intervention. Written informed consent under protocols approved by an institutional or local review board or approved animal protocols are essential if the research involves human or animal subjects, respectively. This information should be stated in the manuscript and the protocol number or exempt status of approved protocols should be stated in the manuscript at the time of submission for review. Ethical considerations must be clearly addressed in the Materials and Methods section. Also the name of the appropriate institutional review board that approved the project should be mentioned. The Journal reserves the right to request the related documents.

Clinical Trial Registration
 In a clinical trial, According to the International Committee of Medical journal Editors (ICMJE), participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or changes to participants' behavior, such as diet. Clinical trials may compare a new medical approach to a standard one that is already available, to a placebo that contains no active ingredients, or to no intervention. Some clinical trials compare interventions that are already available to each other. The investigators try to determine the safety and efficacy of the intervention by measuring certain outcomes in the participants. Authors of clinical trials are required to prospectively register their trial with one of the ICMJE-recognized trial registries. The registration number of the trial and the name of the trial registry must be mentioned at the end of the abstract.

 All of Iranian Clinical Trials must be registered in Iranian Registry of Clinical Trials (, in order to be considered for publication. The clinical trials performed abroad, could be considered for publication, if they register in a registration site approved by W.H.O. such as:

Authorship Criteria and contributions
 Authors' names should be mentioned according to the defined criteria by the International Committee of Medical Journal Editors (ICMJE). Based on the ICMJE recommendations, authors (or one of them) should have all the following criteria: 1) Have a substantial contribution in at least one of the following activities: a) presenting the research conception or designing the study, b) collecting the data, c) analyzing and interpreting; 2) Have a role in drafting the study or revising it critically for important intellectual scientific content; 3) Study and approve the final version to be published; 4) Agree to be accountable for the correctness and accuracy of all aspects of the study; 5) The journal avoids accepting the articles with moral plagiarism (scientific and literary) and fraud according to the existing standards. The contents of the article should not be a copy of similar studies. If the authors use all or part of the published or unpublished materials or ideas of someone else, they must cite references properly or take permission in necessary cases. Useful guidelines for authors can be found on the ICMJE website. In cases of authorship disputes that can not be resolved between the authors, the editors reserve the right to refer the dispute to the institutes involved for resolution. Useful guidelines for researchers on how to avoid authorship disputes can be found on the COPE website. Enter author's all contributions in the submission system during submission.

 Contributions will be published in the final article, and they should accurately reflect contributions in the study. The submitting author is responsible for completing this information at submission, and it is expected that all authors, prior to this time, will have reviewed, discussed, and agreed upon their individual contributions. The contributions of all authors must be described using the CRediT Taxonomy of author's roles.

Role of the Corresponding Author

 One author is assigned as Corresponding Author and acts on behalf of all co-authors and ensures that questions related to the accuracy or integrity of any part of the work are appropriately addressed. The ICMJE recommends that authorship be based on the following 4 criteria:

  • Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND
  • Drafting the work or revising it critically for important intellectual content; AND
  • Final approval of the version to be published; AND
  • Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

 In addition to being accountable for the parts of the work he or she has done, an author should be able to identify which co-authors are responsible for specific other parts of the work. In addition, authors should have confidence in the integrity of the contributions of their co-authors.

Addition, deletion, or rearrange Addition, deletion, or rearrangement of author names in an accepted manuscript’s authorship
 Before the accepted manuscript is published in an online issue
Requests to add or remove an author, or to rearrange the author names, must be sent to the Journal Manager from the corresponding author of the accepted manuscript and must include:
a) The reason the name should be added or removed, or the author names rearranged.
b) Written confirmation (email, fax, letter) from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed.
Requests that are not sent by the corresponding author will be forwarded on by the Journal Manager to the corresponding author, who must follow the procedure as described above.
Note that:

  • Journal managers will inform Editors of any such requests
  • Publication of the accepted manuscript in an online issue is suspended until authorship has been agreed
 After the accepted manuscript is published in an online issue
Any requests to add, delete, or rearrange author names in an article published in an online issue will follow the same policies as noted above and result in a corrigendum.

Author Misconduct
 SBRH will follow the COPE guidelines to deal with any potential misconduct.

Data Fabrication
 Fabrication is the construction and/or addition of data, observations, or characterizations that never occurred in the gathering of data or running of experiments. Fabrication can occur when “filling out” the rest of experiment runs, for example. SBRH will ask the author(s) to provide the raw data for further investigations if necessary.

Data Falsification

 Manipulating research data with the intention of giving a false impression. This includes manipulating images (e.g. micrographs, gels, radiological images), removing outliers or “inconvenient” results, changing, adding or omitting data points, etc. In the initial process of peer review, SBRH tries to consider this issue and act accordingly.


 To avoid duplication, consider the points established by COPE website.
a) Author(s) should clarify that they has not been submitted the manuscript in more than one journal.
b) Author(s) should not publish the submitted manuscript in two different languages (one in a Persian medical journal and the other in another language (English, French, German, etc.), simultaneously.
c) Author(s) should not publish the submitted manuscript in SBRH elsewhere previously as part or full, unless some new results would be considered.
d) Authors should not split up the results of a work to publish them in more than one journal (Salami-Publishing).
  Author(s) should enclose a written undertaking along with manuscript, confirming the above mentioned points with signature of the corresponding author(s).

 Plagiarism is not acceptable in SBRH submissions. Plagiarized content will not be considered for publication. If plagiarism is identified, SBRH will follow the COPE guidelines.

Plagiarism includes:

  • Directly copying text from other sources without attribution;
  • Copying ideas, images, or data from other sources without attribution;
  • Reusing text from your own previous publications without attribution or agreement of the editor (read the COPE guidelines on text recycling);

 If plagiarism is detected during the peer review process, the manuscript may be rejected. If plagiarism is detected after publication, SBRH may perform a correction or retract the paper, as appropriate. SBRH reserves the right to inform authors' institutions about plagiarism detected either before or after publication. The journal uses plagiarism detection software to evaluate the originality of each manuscript before publication.
 SBRH expects that editors and reviewers will be vigilant in their evaluation of SBRH submissions and will notify the journal about any plagiarism identified. Authors should avoid self-plagiarism. It means they do not use the previous own published materials without acknowledgment of the source.

 SBRH mandates ORCID iDs for the first and corresponding authors since 2018. Therefore, authors and reviewers are strongly recommended to also connect their Scholar One accounts to ORCID.

Conflicts of Interest
 According to ICMJE guidelines, a conflict of interest may exist when an author (or the author’s institution), reviewer or editor has personal or financial relationships that influence (bias) inappropriately his/her action (such relationships are also known as dual commitments, competing interests, or competing loyalties). These relationships vary from those with ne